Somaxon Pharmaceuticals Overview
- Year Founded
-
2003
- Status
-
Acquired/Merged
- Employees
-
36
- Latest Deal Type
-
M&A
- Financing Rounds
-
7
Somaxon Pharmaceuticals General Information
Description
Developer of specialty pharmaceuticals. The company's products are used in the treatment of middle ear infections, head lice and cough and cold.
Contact Information
Corporate Office
- 3570 Carmel Mountain Road
- Suite 100
- San Diego, CA 92130
- United States
Corporate Office
- 3570 Carmel Mountain Road
- Suite 100
- San Diego, CA 92130
- United States
Somaxon Pharmaceuticals Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Somaxon Pharmaceuticals Patents
Somaxon Pharmaceuticals Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2009137531-A2 | Compositions and methods related to action of low dosages of doxepin on the h1 and 5-ht2a receptors | Inactive | 06-May-2008 | ||
| WO-2009137531-A3 | Compositions and methods related to action of low dosages of doxepin on the h1 and 5-ht2a receptors | Inactive | 06-May-2008 | ||
| EP-2148659-A2 | Low-dose doxepin formulations | Inactive | 13-Apr-2007 | ||
| WO-2008128115-A2 | Low-dose doxepin formulations | Inactive | 13-Apr-2007 | ||
| WO-2008128115-A3 | Low-dose doxepin formulations | Inactive | 13-Apr-2007 | A61K31/335 |
Somaxon Pharmaceuticals Signals
Somaxon Pharmaceuticals Former Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Somaxon Pharmaceuticals FAQs
-
When was Somaxon Pharmaceuticals founded?
Somaxon Pharmaceuticals was founded in 2003.
-
Where is Somaxon Pharmaceuticals headquartered?
Somaxon Pharmaceuticals is headquartered in San Diego, CA.
-
What is the size of Somaxon Pharmaceuticals?
Somaxon Pharmaceuticals has 36 total employees.
-
What industry is Somaxon Pharmaceuticals in?
Somaxon Pharmaceuticals’s primary industry is Pharmaceuticals.
-
Is Somaxon Pharmaceuticals a private or public company?
Somaxon Pharmaceuticals is a Private company.
-
What is the current valuation of Somaxon Pharmaceuticals?
The current valuation of Somaxon Pharmaceuticals is .
-
What is Somaxon Pharmaceuticals’s current revenue?
The current revenue for Somaxon Pharmaceuticals is .
-
How much funding has Somaxon Pharmaceuticals raised over time?
Somaxon Pharmaceuticals has raised $161M.
-
Who are Somaxon Pharmaceuticals’s investors?
CDIB BioScience Venture Management, Domain Associates, Fog City Fund, Glenn Holdings, and MPM BioImpact are 5 of 10 investors who have invested in Somaxon Pharmaceuticals.
-
When was Somaxon Pharmaceuticals acquired?
Somaxon Pharmaceuticals was acquired on 06-Mar-2013.
-
Who acquired Somaxon Pharmaceuticals?
Somaxon Pharmaceuticals was acquired by Pernix Therapeutical Holdings.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process